Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Cancer Research Technology (CRT) - Advancing Discoveries to Beat Cancer News

Cancer Research Technology (CRT) - Advancing Discoveries to Beat Cancer

Cancer Research UK and Immatics Biotechnologies Launch Trial for Brain Cancer Vaccine Cancer Research UK and Cancer Research Technology - the charity's development and commercialisation arm - together with immatics biotechnologies have launched the first clinical trial of a promising cancer vaccine to treat glioblastoma, one of the most common forms of brain cancer.
View press release
Deal Struck for New Investigational Anti-Cancer Drug toTarget Leukaemia and Lymphoma Cancer Research UK and Cancer Research Technology (CRT), the charity's development and commercialisation arm, are to undertake a phase I clinical trial of an investigational monoclonal antibody drug from Merck KGaA, Darmstadt, Germany, called DI-B4.
View press release
CRT and Bayer Schering Pharma to Investigate New Therapeutic Approach in Gynaecological and Oncological Diseases Cancer Research Technology Ltd. (CRT) has signed an agreement with Bayer Schering Pharma AG, Germany, to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynaecological diseases, including cancer.
View press release
CRT and ValiRx Sign Licensing Deal to Develop Prostate Cancer Treatment Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.
View press release
'Skills Swap' to Exploit Expertise for Patient Benefit Cancer Research Technology (CRT) and Medical Research Council Technology (MRCT) will "swap" medical discoveries to accelerate the translation of early scientific research into patient benefit.
View press release
UK-NZ Collaboration to Hone in on New Anti-Cancer Drug for Leukaemia Cancer Research Technology (CRT) – Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.
View press release
CRT Announces Partnership with Cephalon to Develop a New Class of Anti-Cancer Drugs Cancer Research Technology (CRT) announced today an exclusive agreement with Cephalon, Inc., an international biotechnology company, to collaborate on the development of small molecule inhibitors. These molecules will target specific members of the Protein Kinase C superfamily of cell signalling proteins - which have been shown to be associated with the development of cancer.
View press release
Cancer Research UK and Immatics Biotechnologies to Trial Vaccine for Brain Cancer Cancer Research UK and Cancer Research Technology - the charity's development and commercialisation arm - have reached a collaboration agreement with immatics biotechnologies to trial their new treatment vaccine, IMA950, for glioblastoma multiforme (GMB), one of the most common forms of brain cancer.
View press release
CRT and AstraZeneca Form Major Alliance to Create "Cancer Metabolism" Drugs Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca, in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs.
View press release